Open the mobile version, with barcode scanning
Class II Terminated

Lansoprazole Delayed-Release Orally Disintegrating Tablets 30 mg, 100-count carton (10 x10 unit-dose), Rx only, Manufactured by: Cadila Healthcare Ltd.

Why: Failed Dissolution Specification

Company
Zydus Pharmaceuticals (USA) Inc
Pennington, NJ, United States
Reported
Nov 11, 2020
Recall started
Oct 27, 2020
Ended
Dec 20, 2022
Where sold
Distributed Nationwide in the USA
Amount
7,908 units
Full product description
Lansoprazole Delayed-Release Orally Disintegrating Tablets 30 mg, 100-count carton (10 x10 unit-dose), Rx only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534, NDC 68382-772-77
Lots / codes affected
Lot # M005682, EXP 3/2022

Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.